Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
33.77
Dollar change
+0.91
Percentage change
2.77
%
IndexRUT P/E- EPS (ttm)-1.04 Insider Own8.88% Shs Outstand26.83M Perf Week1.93%
Market Cap909.09M Forward P/E221.20 EPS next Y0.15 Insider Trans-1.48% Shs Float24.53M Perf Month-15.95%
Income-26.59M PEG- EPS next Q0.10 Inst Own90.12% Short Float17.15% Perf Quarter3.11%
Sales160.88M P/S5.65 EPS this Y-147.60% Inst Trans-0.13% Short Ratio9.55 Perf Half Y24.15%
Book/sh10.38 P/B3.25 EPS next Y106.17% ROA-6.04% Short Interest4.21M Perf Year117.87%
Cash/sh12.89 P/C2.62 EPS next 5Y- ROE-9.69% 52W Range15.32 - 43.81 Perf YTD7.10%
Dividend Est.- P/FCF- EPS past 5Y12.40% ROI-8.73% 52W High-22.92% Beta2.60
Dividend TTM- Quick Ratio4.72 Sales past 5Y295.95% Gross Margin- 52W Low120.43% ATR (14)2.13
Dividend Ex-Date- Current Ratio4.72 EPS Y/Y TTM-395.33% Oper. Margin-4.30% RSI (14)44.30 Volatility6.50% 6.15%
Employees180 Debt/Eq0.11 Sales Y/Y TTM-21.90% Profit Margin-16.53% Recom1.30 Target Price67.62
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q-107.43% Payout0.00% Rel Volume1.20 Prev Close32.86
Sales Surprise-10.23% EPS Surprise67.75% Sales Q/Q-82.40% EarningsMar 07 AMC Avg Volume440.19K Price33.77
SMA20-6.13% SMA50-6.37% SMA20013.83% Trades Volume527,835 Change2.77%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Initiated Canaccord Genuity Buy $90
Jul-24-23Initiated William Blair Outperform $71
May-11-23Upgrade H.C. Wainwright Neutral → Buy $19 → $51
Nov-14-22Resumed Wells Fargo Overweight $35
Nov-10-22Downgrade Robert W. Baird Neutral → Underperform $18
Nov-03-22Upgrade Citigroup Neutral → Buy $22 → $35
Nov-02-22Upgrade Barclays Underweight → Equal Weight $16 → $25
Aug-10-22Downgrade Raymond James Mkt Perform → Underperform
Jul-19-22Resumed Cantor Fitzgerald Overweight $86 → $39
May-11-22Upgrade Robert W. Baird Underperform → Neutral $21 → $18
Today 01:34AM
Mar-22-24 01:26AM
Mar-09-24 01:09PM
Mar-08-24 12:10PM
06:54AM
10:42PM Loading…
Mar-07-24 10:42PM
05:10PM
04:21PM
04:01PM
Mar-04-24 01:23PM
Feb-26-24 03:20PM
09:00AM
Feb-22-24 08:30AM
Feb-21-24 01:04PM
Feb-20-24 04:39PM
09:00AM Loading…
09:00AM
Feb-05-24 08:30AM
Jan-23-24 04:16AM
Jan-05-24 01:17PM
Dec-21-23 08:00AM
Dec-17-23 12:03PM
Dec-13-23 10:39PM
Dec-08-23 10:13AM
Dec-04-23 08:30AM
Nov-28-23 08:05AM
07:56AM
Nov-27-23 08:30AM
Nov-15-23 01:26PM
11:30AM
Nov-14-23 05:19PM
04:13PM Loading…
04:13PM
04:01PM
10:56AM
Oct-25-23 04:01PM
Oct-23-23 04:01PM
Oct-04-23 11:01PM
08:30AM
Sep-26-23 08:30AM
Sep-19-23 08:30AM
Sep-05-23 08:30AM
Aug-17-23 08:30AM
Aug-14-23 09:00AM
Aug-10-23 07:15AM
Aug-08-23 02:39PM
01:09PM
08:43AM
07:39AM
Aug-07-23 07:50PM
06:43PM
04:01PM
Aug-04-23 09:21AM
Jul-28-23 05:14PM
Jul-24-23 04:01PM
Jul-18-23 06:22AM
Jul-16-23 08:18PM
Jul-14-23 02:36PM
Jul-05-23 06:15AM
Jun-14-23 08:24AM
Jun-01-23 08:30AM
May-18-23 07:16AM
May-12-23 02:04AM
May-09-23 05:35PM
04:37PM
04:01PM
09:29AM
May-08-23 07:43AM
Apr-28-23 01:39PM
Apr-26-23 08:30AM
Apr-17-23 07:10AM
Mar-30-23 08:29AM
Mar-29-23 11:45AM
Mar-28-23 05:15PM
04:01PM
Mar-27-23 09:11AM
Mar-23-23 06:18AM
Mar-07-23 08:00AM
Feb-06-23 08:30AM
Jan-31-23 08:30AM
Dec-28-22 11:35AM
Dec-19-22 08:30AM
Dec-13-22 08:30AM
Dec-12-22 08:30AM
Dec-01-22 10:23AM
Nov-16-22 05:24AM
Nov-12-22 07:04AM
Nov-09-22 05:25PM
04:01PM
Nov-07-22 05:00PM
Nov-04-22 05:46AM
Nov-02-22 12:00PM
07:43AM
Nov-01-22 06:05PM
06:00PM
08:55AM
Oct-26-22 04:30PM
Oct-18-22 08:05AM
Sep-27-22 06:00PM
Sep-22-22 12:28PM
Sep-07-22 06:44AM
Sep-01-22 04:00PM
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chivukula PadChief Scientific Officer & COOMar 25 '24Sale35.0217,435610,574473,448Mar 27 04:15 PM
Chivukula PadChief Scientific Officer & COOMar 19 '24Sale35.018,565299,839490,883Mar 21 05:27 PM
Chivukula PadChief Scientific Officer & COONov 01 '23Sale18.725,00093,602499,448Nov 03 04:30 PM
Chivukula PadChief Scientific Officer & COOOct 02 '23Sale25.615,000128,062504,448Oct 04 04:06 PM
Chivukula PadChief Scientific Officer & COOSep 01 '23Sale31.455,000157,264509,448Sep 05 04:05 PM
Chivukula PadChief Scientific Officer & COOAug 01 '23Sale34.915,000174,550514,448Aug 03 04:15 PM
Kummerfeld Keith CSee RemarksJul 14 '23Option Exercise8.966,96862,4087,918Jul 18 06:50 PM
Chivukula PadChief Scientific Officer & COOJul 14 '23Sale35.0125,000875,250519,448Jul 18 06:50 PM
Kummerfeld Keith CSee RemarksJul 14 '23Sale35.006,968243,880950Jul 18 06:50 PM
Chivukula PadChief Scientific Officer & COOJul 03 '23Sale28.755,000143,750544,448Jul 07 06:01 AM
Chivukula PadChief Scientific Officer & COOJun 01 '23Sale27.165,000135,800549,448Jun 05 04:07 PM
Chivukula PadChief Scientific Officer & COOMay 11 '23Sale30.247,925239,652554,448May 12 04:05 PM
Chivukula PadChief Scientific Officer & COOMay 10 '23Sale30.0017,075512,250562,373May 12 04:05 PM
Chivukula PadChief Scientific Officer & COOMay 01 '23Sale25.935,000129,650579,448May 03 04:08 PM
Kummerfeld Keith CSee RemarksApr 18 '23Option Exercise8.966,96862,4087,918Apr 19 04:57 PM
Kummerfeld Keith CSee RemarksApr 18 '23Sale28.186,968196,358950Apr 19 04:57 PM
Chivukula PadChief Scientific Officer & COOApr 03 '23Sale25.385,000126,900584,448Apr 05 08:47 PM